Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Esmolol to Treat the Hemodynamic Effects of Septic Shock

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02369900
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:07.508287+00:00
Published At
2021-06-28T00:00:00+00:00
Record Updated At
2021-06-28
Results Posted At
2021-06-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Septic Shock", "Hypotension", "Tachycardia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-28"
protocolSection.identificationModule.nctId
"NCT02369900"
protocolSection.identificationModule.officialTitle
"Esmolol to Treat the Hemodynamic Effects of Septic Shock"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-06-28"

Study condition terms

  • Septic Shock (protocolSection.conditionsModule.conditions)
  • Hypotension (protocolSection.conditionsModule.conditions)
  • Tachycardia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.